Christopher Mews Named Director of RooLife Group, Discloses Spouse’s 11 Million Shareholding

Christopher Mews Joins RooLife Group Board Effective 1 July 2026

RooLife Group Ltd has officially notified the market of Christopher Mews’ appointment as a director, effective 1 July 2026, through an Appendix 3X Initial Director's Interest Notice. This regulatory form, mandated by ASX Listing Rule 3.19A.1, details a new director’s relevant securities interests at the time of joining, ensuring transparency from the outset.

The notice does not provide additional biographical or professional details about Mews, nor specify whether he will serve as an executive, non-executive, or independent director. Investors seeking further information on his background or strategic mandate should await any supplementary company announcements. There was no immediate impact on the company’s share price evident from public data.

No Direct Securities Held by Mews at Appointment

Part 1 of the Appendix 3X confirms that Christopher Mews held no RooLife Group securities directly as of 1 July 2026. He owns no fully paid ordinary shares, options, performance rights, or other securities registered in his name at the time of appointment.

It is common for newly appointed directors to start without direct holdings, especially if future incentive securities require shareholder approval. Any future acquisitions by Mews would trigger a Change of Director's Interest Notice (Appendix 3Y) to keep the market informed. Investors should watch for such filings to track changes in his holdings.

Spouse Rachel Leanne Marques Holds 11,010,000 Shares via Hill Valley Account

Although Mews holds no direct securities, Part 2 of the notice reveals an indirect interest: his spouse, Rachel Leanne Marques, owns 11,010,000 fully paid ordinary shares in RooLife Group through the Hill Valley A/c. Under the Corporations Act and ASX Listing Rules, directors must disclose relevant interests held by associates, including spouses, as these constitute notifiable interests.

The 11,010,000 shares represent a significant stake, though the exact percentage of issued capital is not specified in the filing since the company’s total shares outstanding were not included. Investors can consult RooLife Group’s latest Annual Report or ASX Capital Structure disclosures for context. The announcement does not provide this figure.

No Contractual Interests Declared by Christopher Mews

Part 3 of the Appendix 3X, which requires disclosure of any contracts between the director and the company, is marked as not applicable. This indicates Mews has no declared contractual interests with RooLife Group at appointment.

This absence of contractual interests is typical for new directors. Should Mews enter into agreements such as consulting or service contracts in the future, these will require disclosure in subsequent filings. Market participants should note this as a clean slate with no related-party contracts declared upon joining.

Regulatory Basis for the Initial Director's Interest Notice

The Appendix 3X form, governed by ASX Listing Rule 3.19A.1 since 30 September 2001, ensures continuous disclosure of directors’ securities interests from the moment they join a listed company. This supports investor transparency regarding any alignment or conflicts between directors’ financial interests and those of shareholders.

Under section 205G of the Corporations Act 2001, directors must notify the company of their relevant securities interests. RooLife Group’s lodgement of this notice on behalf of Mews fulfills these legal and regulatory obligations. Any missing information must be provided to the ASX promptly as it becomes available.

Understanding the Hill Valley Account Shareholding Structure

The shares held by Rachel Leanne Marques are registered under the "Hill Valley A/c," a common Australian practice involving personal or family trust accounts. This naming convention is administrative and does not imply complex ownership. Marques is explicitly identified as Mews’ spouse, triggering the disclosure requirement.

Since the shares are registered in Marques’ name, Mews does not directly control or own them. Disclosure is required because of his indirect relevant interest through his spouse. Voting and disposal rights remain with Marques unless undisclosed arrangements exist.

Ongoing Disclosure Obligations for Director Interests

Following this initial notice, RooLife Group and Mews must comply with ongoing disclosure requirements under Listing Rule 3.19A.2. Any changes to Mews’ direct or indirect securities interests—including acquisitions, disposals, or option exercises—must be reported via Appendix 3Y filings.

Investors tracking RooLife Group’s board composition and shareholder register should monitor these filings to understand how Mews’ alignment with the company evolves. Whether he acquires direct shares or equity remuneration, or if his spouse’s holdings change, all updates will be publicly available through the ASX.

Investor Considerations Amid RooLife Group’s Board Change

RooLife Group operates in cross-border e-commerce, facilitating sales of Australian and international brands into Asian markets, especially China. Board appointments can signal strategic shifts or governance developments. However, no accompanying statement or strategic rationale for Mews’ appointment was provided in the filing.

Market participants will likely await further company communications detailing Mews’ expertise and expected contributions. Potential links to capital initiatives, partnerships, or governance changes remain speculative until additional information is released. For now, this announcement serves as a mandatory regulatory disclosure of the new director and his initial interests.

Upcoming Milestones Following the Disclosure

The next key update for investors will be any supplementary announcement from RooLife Group providing biographical and strategic context on Mews’ appointment. Although not required within the Appendix 3X, companies often issue such details concurrently or shortly after the initial notice.

Subsequent Appendix 3Y filings will also be important for tracking any changes in Mews’ securities interests. The existing 11,010,000 shares held by his spouse establish an indirect connection to RooLife Group’s performance, and any future adjustments will be disclosed promptly to the market.